Home / Oligonucleotides and Peptides / Development and manufacturing / Drug products
TIDES drug products
Integrated peptide and oligonucleotide drug product services, designed to deliver flexibility, precision, and dependable progress from formulation through commercial supply.
TIDES drug product solutions tailored to your molecule and goals.
We provide fully integrated peptide and oligonucleotide drug product development and manufacturing services designed to streamline your path from early formulation through commercial supply. With experience across a wide range of molecule types and formulation requirements, we collaborate closely with you to tailor solutions that match the complexity and pace of your program.
Our teams work as an extension of yours, aligning on goals, anticipating challenges, and coordinating seamlessly across disciplines. From pre-formulation through clinical and commercial production, we manage transitions with care, ensuring continuity, consistency, and efficiency at every step. Whether you’re progressing a liquid or lyophilized format, or planning for a combination product, we deliver with the precision your project demands.
Complexity doesn’t slow us down – it drives us forward. With deep expertise and a purpose-built platform dedicated to peptides, we help reduce risk, avoid delays, and keep your development on track. Our service model is built on flexibility and focus, designed to move with your needs and evolve alongside your molecule.
70,000,000 units
Our technology
Our advanced technologies support a wide range of peptide and oligonucleotide drug product formats, including liquid, lyophilized, and pre-filled syringes.
We offer scalable solutions across formulation, aseptic fill-finish, and visual inspection, with integrated isolator systems to ensure sterility and containment. Guided by precision and built for flexibility, our platform supports seamless transitions from development to commercial launch.
We combine specialized expertise with cutting-edge equipment to simplify complexity and drive your program forward.
Our quality
Quality underpins every step of our TIDES drug product development and manufacturing. Our dedicated teams apply robust control strategies and deep regulatory knowledge to ensure consistency, compliance, and patient safety.
With a mindset shaped by experience and a commitment to precision, we manage complexity without compromise. At WuXi TIDES, quality is not a checkpoint. It is a continuous, collaborative practice that drives dependable outcomes from early formulation through to commercial release.
Our locations
Our global network of TIDES drug product facilities spans North America, Europe, and Asia, offering fully integrated development and manufacturing support.
From early-phase formulation to commercial-scale fill-finish, our sites are designed to deliver with consistency and speed. Combining local focus with global strength, we turn complexity into progress.
At WuXi TIDES, proximity to expertise means your peptide and oligonucleotide therapies are always in capable hands – ready to advance wherever your program takes you.
Our history
From its foundation, our journey has been defined by a commitment to innovation, quality, and strong partnerships, driven by a purpose-driven pace.
We’ve evolved into a leading CRDMO with a perfectly orchestrated platform, consistently expanding our global footprint and capabilities to accelerate breakthroughs for our partners and patients worldwide.
Related services
Related content
Quantum Mechanics for Organic Chemists
Quantum Mechanics, Molecular Orbital Theory in particular, enables us to understand organic reactions at deeper levels.
Frequently Asked Questions
QM Magic Class | Chapter 38 Over the years, we received a lot of questions from our readers, below are...
WuXi STA Forms Strategic Partnership with Beta Pharma
STA will Accelerate Process R&D and Manufacturing of Late Phase and Commercial Targets STA Pharmaceutical Co., Ltd., (WuXi STA) –...